Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,735 | 165 | 99.9% |
| Education | $6.97 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,269 | 38 | $0 (2024) |
| Abbott Laboratories | $1,038 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $722.84 | 23 | $0 (2024) |
| Boston Scientific Corporation | $655.04 | 13 | $0 (2024) |
| Kestra Medical Technology Services, Inc. | $537.41 | 8 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $346.50 | 6 | $0 (2022) |
| Amgen Inc. | $337.53 | 16 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $227.39 | 2 | $0 (2018) |
| ShockWave Medical, Inc | $146.14 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $135.79 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,085 | 25 | Kestra Medical Technology Services, Inc. ($478.14) |
| 2023 | $919.06 | 20 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($157.88) |
| 2022 | $692.15 | 14 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($220.87) |
| 2021 | $319.88 | 7 | Esperion Therapeutics, Inc. ($124.00) |
| 2020 | $160.34 | 7 | Boston Scientific Corporation ($107.21) |
| 2019 | $802.51 | 14 | Abbott Laboratories ($439.63) |
| 2018 | $1,009 | 30 | Novartis Pharmaceuticals Corporation ($228.83) |
| 2017 | $1,755 | 49 | Abbott Laboratories ($505.98) |
All Payment Transactions
166 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Structural Heart | ||||||
| 12/03/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $15.89 | General |
| Category: Cardiology | ||||||
| 11/15/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.78 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/30/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $118.00 | General |
| Category: Cardiology | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $93.56 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: LUX-Dx_CRM | ||||||
| 08/09/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $24.60 | General |
| Category: Cardiology | ||||||
| 07/24/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: LUX-Dx_CRM | ||||||
| 07/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.82 | General |
| Category: Cardiovascular | ||||||
| 07/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $25.28 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/28/2024 | Boston Scientific Corporation | EMBLEM MRI S-ICD (Device) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: EMBLEM_CRM | ||||||
| 06/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.97 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Cardiology | ||||||
| 05/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Cardiology | ||||||
| 05/15/2024 | Philips North America LLC | (6571) Eagle Eye (Device) | Food and Beverage | Cash or cash equivalent | $102.39 | General |
| Category: Medical Device | ||||||
| 05/07/2024 | Philips North America LLC | (6571) Eagle Eye (Device) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Medical Device | ||||||
| 04/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: DIABETES | ||||||
| 03/20/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $4.83 | General |
| Category: Cardiology | ||||||
| 03/19/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $91.04 | General |
| Category: Cardiology | ||||||
| 02/22/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $223.78 | General |
| Category: Cardiology | ||||||
| 01/25/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $99.12 | General |
| 01/25/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.42 | General |
| 01/25/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.85 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,929 | 2,933 | $411,808 | $191,556 |
| 2022 | 30 | 1,994 | 3,009 | $384,233 | $172,252 |
| 2021 | 25 | 2,107 | 3,888 | $465,881 | $222,403 |
| 2020 | 29 | 2,145 | 3,827 | $406,563 | $191,053 |
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 273 | 665 | $56,975 | $43,399 | 76.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 344 | 631 | $63,100 | $40,774 | 64.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 166 | 189 | $47,250 | $27,083 | 57.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 90 | 90 | $27,000 | $12,825 | 47.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 80 | 80 | $26,000 | $11,851 | 45.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 47 | 87 | $11,015 | $8,593 | 78.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 81 | $12,150 | $8,135 | 67.0% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 45 | 45 | $19,125 | $7,792 | 40.7% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 30 | 30 | $13,500 | $5,534 | 41.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 33 | 33 | $13,200 | $5,197 | 39.4% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 44 | 44 | $9,900 | $3,813 | 38.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 64 | 64 | $56,108 | $3,358 | 6.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 257 | 310 | $15,810 | $3,264 | 20.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $4,200 | $1,918 | 45.7% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 16 | 16 | $3,600 | $1,548 | 43.0% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 18 | 164 | $8,200 | $1,395 | 17.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 139 | 160 | $7,706 | $1,003 | 13.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 15 | 20 | $2,460 | $997.25 | 40.5% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 28 | 42 | $3,150 | $602.58 | 19.1% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 17 | 17 | $2,975 | $580.16 | 19.5% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 13 | 20 | $2,400 | $478.78 | 19.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 15 | 23 | $1,725 | $442.80 | 25.7% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 16 | 16 | $2,204 | $302.55 | 13.7% |
| 93042 | Electrocardiogram (ecg) 1 to 3 leads with review by physician only | Facility | 2023 | 44 | 45 | $450.00 | $252.45 | 56.1% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 18 | 19 | $1,045 | $209.90 | 20.1% |
About Dr. Anthony Kawa, DO
Dr. Anthony Kawa, DO is a Cardiovascular Disease healthcare provider based in St Clair Shores, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881643955.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Kawa, DO has received a total of $6,742 in payments from pharmaceutical and medical device companies, with $1,085 received in 2024. These payments were reported across 166 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($6,735).
As a Medicare-enrolled provider, Kawa has provided services to 8,175 Medicare beneficiaries, totaling 13,657 services with total Medicare billing of $777,264. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location St Clair Shores, MI
- Active Since 05/08/2006
- Last Updated 12/01/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1881643955
Products in Payments
- LifeVest (Device) $1,269
- ENTRESTO (Drug) $700.18
- Assure WCD (Device) $537.41
- CardioMEMS HF System (Device) $357.24
- Accessories (Structural Intervention) (Device) $345.78
- PRALUENT (Drug) $227.39
- Repatha (Biological) $209.95
- UPTRAVI (Drug) $195.62
- HeartMate 3 Left Ventricular Dev (Device) $163.88
- EMBLEM MRI S-ICD (Device) $148.40
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $146.14
- WATCHMAN Access System (Device) $130.04
- BRILINTA (Drug) $128.21
- Corlanor (Drug) $127.58
- (6571) Eagle Eye (Device) $127.39
- XARELTO (Drug) $125.42
- NEXLIZET (Drug) $124.00
- JARDIANCE (Drug) $123.14
- PRALUENT ALIROCUMAB INJECTION (Biological) $122.76
- VERQUVO (Drug) $118.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in St Clair Shores
Thomas Davis, Md, MD
Cardiovascular Disease — Payments: $198,978
Thomas Lalonde, Md, MD
Cardiovascular Disease — Payments: $120,188
Marc Gosselin, Do, DO
Cardiovascular Disease — Payments: $64,404
Brilio Mojares, Md, MD
Cardiovascular Disease — Payments: $24,512
Dr. George Ghanem, Md, MD
Cardiovascular Disease — Payments: $2,027
Georges Ghafari, Md, MD
Cardiovascular Disease — Payments: $1,696